Research Grants 93 show all


$1.5M
2016

$18.5M
2017

$14.9M
2018

$24.9M
2019

$3.3M
2020

Patents 307show all

  • 79
    A61K - Preparations for medical, dental, or toilet purposes
  • 52
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 50
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 47
    C07K - Peptides
  • 46
    C12N - Microorganisms or enzymes
  • 7
    A61N - Electrotherapy
  • 7
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 4
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4
    Y02A - Technologies for adaptation to climate change
  • 3
    C07D - Heterocyclic compounds

Publications 8,986 show all

  • 465
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 261
    Antineoplastic Agents/therapeutic use
  • 149
    Neoplasms/drug therapy
  • 138
    Lung Neoplasms/drug therapy
  • 138
    Neoplasms/therapy
  • 111
    Carcinoma, Non-Small-Cell Lung/drug therapy
  • 104
    Kidney Neoplasms/drug therapy
  • 100
    Carcinoma, Renal Cell/drug therapy
  • 95
    Breast Neoplasms/drug therapy
  • 86
    Breast Neoplasms/pathology

Clinical Trials 758show all

242Phase 2226Phase 380Phase 178N/A58Phase 1/Phase 224Other

Contact Information

Villejuif
France